Gd-doped BNNTs asT2-weighted MRI contrast agents
Source abstract
Abstract
This work describes, for the first time, doping of boron nitride nanotubes (BNNTs) with gadolinium (Gd@BNNTs), a stable functionalization that permits non-invasive BNNT tracking via magnetic resonance imaging (MRI). We report the structure, Gd loading, and relaxometric properties in water suspension at 7 T of Gd@BNNTs, and show the behaviour of these nanostructures as promising T2-weighted contrast agents. Finally, we demonstrate their complete biocompatibility in vitro on human neuroblastoma cells, together with their ability to effectively label and affect contrast in MRI images at 7 T.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Boron Compounds in Chemistry · Graphene research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. 10.1039/c0nr00335b10.1039/c0nr00335b ↗
2. 10.1016/j.mser.2010.06.00410.1016/j.mser.2010.06.004 ↗
3. 10.1002/smll.20120131510.1002/smll.201201315 ↗
4. 10.1021/ja807334b10.1021/ja807334b ↗
5. 10.1021/nn101985a10.1021/nn101985a ↗
6. 10.1016/j.actbio.2010.02.04410.1016/j.actbio.2010.02.044 ↗
7. 10.1016/j.ijpharm.2011.12.00210.1016/j.ijpharm.2011.12.002 ↗
8. 10.1021/jz100895s10.1021/jz100895s ↗
9. 10.1016/j.toxlet.2006.11.00110.1016/j.toxlet.2006.11.001 ↗
10. 10.1016/j.nano.2009.07.00310.1016/j.nano.2009.07.003 ↗
11. 10.1021/cr980440x10.1021/cr980440x ↗
12. 10.1039/c2cp41300k10.1039/c2cp41300k ↗
13. Sitharaman B · Chem. Commun. · 2005 · 391510.1039/b504435a ↗
14. 10.1002/cmmi.41010.1002/cmmi.410 ↗
15. 10.1016/j.biomaterials.2010.08.03410.1016/j.biomaterials.2010.08.034 ↗
16. 10.1155/2010/54045610.1155/2010/540456 ↗
17. 10.1016/j.materresbull.2012.11.01210.1016/j.materresbull.2012.11.012 ↗
18. 10.1016/j.jcis.2012.01.04910.1016/j.jcis.2012.01.049 ↗
19. 10.1016/j.bbrc.2010.03.03510.1016/j.bbrc.2010.03.035 ↗
20. 10.1006/abio.1997.217710.1006/abio.1997.2177 ↗
21. 10.1097/01.rli.0000184756.66360.d310.1097/01.rli.0000184756.66360.d3 ↗
22. 10.1002/cmmi.10010.1002/cmmi.100 ↗
23. 10.1097/RLI.0b013e3181ebd4e310.1097/RLI.0b013e3181ebd4e3 ↗
24. 10.1038/nnano.2010.20310.1038/nnano.2010.203 ↗
25. 10.1039/b920348f10.1039/b920348f ↗
26. Wong K · Proc. Int. Soc. Magn. Reson. Med. · 2008 · 16 · 1665
27. 10.1002/cmmi.41010.1002/cmmi.410 ↗
28. 10.1021/jp907891n10.1021/jp907891n ↗
29. 10.1002/adfm.20110282610.1002/adfm.201102826 ↗
30. 10.1021/cr100025t10.1021/cr100025t ↗
31. 10.1016/j.ccr.2008.05.00610.1016/j.ccr.2008.05.006 ↗
32. Wagner F M · J. Instrum. · 2012 · 7 · 0304110.1088/1748-0221/7/03/C03041 ↗
33. Ciani L · Expert Opin. Drug Discov. · 2012 · 7 · 101710.1517/17460441.2012.717530 ↗
34. 10.1039/c1jm11608h10.1039/c1jm11608h ↗